Middle East and Africa Radiotherapy Market Growth Factors 2021
The Middle East and Africa Radiotherapy Market was worth $490.5 million in 2016 and estimated to be growing at a CAGR of 5.8%, to reach $650.29 million by 2021.
(EMAILWIRE.COM, December 26, 2017 ) The Middle East and Africa radiotherapy devices market is scattered across major geographies and seems to be witnessing relatively good growth across the key regional markets. An increasing expenditure on healthcare and sudden rise in the occurrence of cancer across the globe are the main drivers boosting revenue growth of the radiotherapy devices market at a Middle East and Africa level. Further, governments of several countries are allocating a large share of their healthcare budget towards cancer research and bolstering this by implementing several awareness campaigns at a national level. These ancillary drivers are also fuelling revenue growth of the Middle East and Africa radiotherapy devices market to a significant extent.
Middle East and Africa Radiotherapy: Drivers & Restraints
The worldwide radiotherapy market is driven by various components like an expansion in the quantity of tumor patients, diminishment in the cost of treatment in many created nations, colossal government and non government interests in Research and Development of malignancy treatment and inclination for non intrusive systems of treatment. In any case, the absence of gifted staff to play out the treatment, equipped option treatment, its powerlessness to be utilized for metastasis condition of malignancy and symptoms like skin rashes, scar tissue development have controlled the market development.
Get accurate market forecast and analysis on the Middle East and Africa Radiotherapy. Request a sample to stay up-to-date on the main trends affecting this market: http://www.marketdataforecast.com/market-reports/middle-east-and-africa-radiotherapy-market-820/request-sample
Middle East and Africa Radiotherapy: Segmentation
Middle East and Africa Radiotherapy Market, by Type
• External Beam Radiotherapy
o Intensity-modulated Radiotherapy (IMRT)
o Image-guided Radiotherapy (IGRT)
o TomoTherapy
o Stereotactic Therapy
o 3D Conformal Radiotherapy
o Particle Beam Therapy
o Volumetric Modulated Arc Therapy
• Internal Beam Radiotherapy
o Low-dose Rate (LDR)
o High-dose Rate (HDR)
• Systemic Radiotherapy
o Intravenous Radiotherapy
o Oral Radiotherapy
o Instillation Radiotherapy
Middle East and Africa Radiotherapy Market, by Application
• External Beam Therapy
o Prostate Cancer
o Breast Cancer
o Lung Cancer
o Head & Neck Cancer
o Colorectal Cancer
o Others
• Internal Beam Therapy
o Prostate Cancer
o Gynecological Cancer
o Breast Cancer
o Cervical Cancer
o Penile Cancer
o Others
Middle East and Africa Radiotherapy Market, by End User
• Hospitals
• Ambulatory Radiotherapy Centers
• Cancer Research Institutes
Middle East and Africa Radiotherapy: Overview
Radiotherapy is a treatment for cancer which uses beams of high energy radiation to kill cancer tissues in the body. This therapy stops cancer cells from multiplying. Also called radiation therapy, radiotherapy is emerging as a major technology for killing the cancer disease. The Middle East and Africa radiotherapy market is a widely growing sector in recent years.
The Middle East and Africa radiotherapy market could be segmented into three categories, on the basis of types into: external beam radiation therapy, internal radiation therapy and systemic radiation therapy, on the basis of technology into: external beam radiation therapy (image guided radio therapy, intensity modulated radiation therapy, tomotherapy, 3-D conformal radiotherapy, adaptive radiation therapy and others), internal beam radio therapy (low dose rate, high dose rate), and systemic radiation therapy.
Middle East and Africa Radiotherapy: Region-wise Outlook
Based on geography the market is analysed under various regions namely, Middle-East and Africa. Africa is leading the market in this region while Middle-East and estimated to witness highest growth rate in the coming years.
Key Questions Answered
• What is the current and future Radiotherapy outlook in Middle East and Africa? What trends are affecting the Middle East and Africa market?
• What is the competitive landscape and market share of major players in the Breathalyzers space in Middle East and Africa?
• What are the key, high growth markets that Breathalyzers manufacturers should expand into? Which market segments are growing the fastest?
• What are the unmet needs with the Breathalyzers currently on the market? How will emerging technologies fulfil these unmet needs?
• What is physician perception and market outlook of Breathalyzers?
• What are the challenges and barriers that have hindered widespread adoption of Breathalyzers?
Middle East and Africa Radiotherapy: Key Players
Nordion Inc. (Canada), RaySearch Laboratories AB (Sweden), Ion Beam Applications SA (Belgium), C. R. Bard Inc. (U.S.), Mevion Medical Systems Inc. (U.S.), Varian Medical Systems Inc. (U.S.), IsoRay Medical Inc. (U.S.), Elekta AB (Sweden), Accuray Incorporated (U.S.), and Mitsubishi Electric Corporation (Japan) are the major players of Middle East and Africa Radiotherapy market.
Middle East and Africa Radiotherapy: Drivers & Restraints
The worldwide radiotherapy market is driven by various components like an expansion in the quantity of tumor patients, diminishment in the cost of treatment in many created nations, colossal government and non government interests in Research and Development of malignancy treatment and inclination for non intrusive systems of treatment. In any case, the absence of gifted staff to play out the treatment, equipped option treatment, its powerlessness to be utilized for metastasis condition of malignancy and symptoms like skin rashes, scar tissue development have controlled the market development.
Get accurate market forecast and analysis on the Middle East and Africa Radiotherapy. Request a sample to stay up-to-date on the main trends affecting this market: http://www.marketdataforecast.com/market-reports/middle-east-and-africa-radiotherapy-market-820/request-sample
Middle East and Africa Radiotherapy: Segmentation
Middle East and Africa Radiotherapy Market, by Type
• External Beam Radiotherapy
o Intensity-modulated Radiotherapy (IMRT)
o Image-guided Radiotherapy (IGRT)
o TomoTherapy
o Stereotactic Therapy
o 3D Conformal Radiotherapy
o Particle Beam Therapy
o Volumetric Modulated Arc Therapy
• Internal Beam Radiotherapy
o Low-dose Rate (LDR)
o High-dose Rate (HDR)
• Systemic Radiotherapy
o Intravenous Radiotherapy
o Oral Radiotherapy
o Instillation Radiotherapy
Middle East and Africa Radiotherapy Market, by Application
• External Beam Therapy
o Prostate Cancer
o Breast Cancer
o Lung Cancer
o Head & Neck Cancer
o Colorectal Cancer
o Others
• Internal Beam Therapy
o Prostate Cancer
o Gynecological Cancer
o Breast Cancer
o Cervical Cancer
o Penile Cancer
o Others
Middle East and Africa Radiotherapy Market, by End User
• Hospitals
• Ambulatory Radiotherapy Centers
• Cancer Research Institutes
Middle East and Africa Radiotherapy: Overview
Radiotherapy is a treatment for cancer which uses beams of high energy radiation to kill cancer tissues in the body. This therapy stops cancer cells from multiplying. Also called radiation therapy, radiotherapy is emerging as a major technology for killing the cancer disease. The Middle East and Africa radiotherapy market is a widely growing sector in recent years.
The Middle East and Africa radiotherapy market could be segmented into three categories, on the basis of types into: external beam radiation therapy, internal radiation therapy and systemic radiation therapy, on the basis of technology into: external beam radiation therapy (image guided radio therapy, intensity modulated radiation therapy, tomotherapy, 3-D conformal radiotherapy, adaptive radiation therapy and others), internal beam radio therapy (low dose rate, high dose rate), and systemic radiation therapy.
Middle East and Africa Radiotherapy: Region-wise Outlook
Based on geography the market is analysed under various regions namely, Middle-East and Africa. Africa is leading the market in this region while Middle-East and estimated to witness highest growth rate in the coming years.
Key Questions Answered
• What is the current and future Radiotherapy outlook in Middle East and Africa? What trends are affecting the Middle East and Africa market?
• What is the competitive landscape and market share of major players in the Breathalyzers space in Middle East and Africa?
• What are the key, high growth markets that Breathalyzers manufacturers should expand into? Which market segments are growing the fastest?
• What are the unmet needs with the Breathalyzers currently on the market? How will emerging technologies fulfil these unmet needs?
• What is physician perception and market outlook of Breathalyzers?
• What are the challenges and barriers that have hindered widespread adoption of Breathalyzers?
Middle East and Africa Radiotherapy: Key Players
Nordion Inc. (Canada), RaySearch Laboratories AB (Sweden), Ion Beam Applications SA (Belgium), C. R. Bard Inc. (U.S.), Mevion Medical Systems Inc. (U.S.), Varian Medical Systems Inc. (U.S.), IsoRay Medical Inc. (U.S.), Elekta AB (Sweden), Accuray Incorporated (U.S.), and Mitsubishi Electric Corporation (Japan) are the major players of Middle East and Africa Radiotherapy market.
Contact Information:
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results